The Anti-Munchies Drug

[catbirdseat]

A new drug being developed by Sanofi-Synthelabo called rimonabant works by blocking the same receptors in the brain that are activated by cannabinoids when you smoking pot. It was shown to be effective in smoking cessation and in weight loss, especially in the waist, or so-called "visceral fat". This is going to be a gold mine for Sanofi. Now is the time to buy some stock in the company. This is going to be the greatest thing since sliced bread.

[willstrickland]

NYSE ticker symbol: ADR

[chucK]

Thanks a lot guys .

 

Now if we go buy and make a bunch of cash we'll be in trouble for insider trading .

[catbirdseat]

This isn't insider information. The payoff, if there is one, would only come in about two years when the final results of the phase III clinical trials are made public. So here's my take. The phase II trials are large enough to show significant efficacy. The phase III trials will reveal if there are any relatively rare side effects. If it looks good, I'd say this is a drug worth $2-4 billion a year.

[scott_harpell]

Thanks a lot guys .

 

Now if we go buy and make a bunch of cash we'll be in trouble for insider trading .

 

It aint insider information if it is in the newspaper.

[foraker]

Correction, the stock ticker symbol is SNY

[catbirdseat]

Okay folks, now I want to know who took my advice to buy Sanofi stock?

 

Latest articles on Acomplia (rimonabant).

[Dru]

In 6 months time side effects will be shown to include things like constant diahhorea, brain tumors or suicide and then where will all you speculative stock buyers be then?

[catbirdseat]

Time will tell.

[Bogen]

and like those or worse side-effects would stop the lose-weight-without-effort types. Paxil has all those and more, AND no clinical evidence of its efficacy; they seem to be doing ok.

[Skeezix]

Boom-jiggy, boom-jiggy, boom, boom, boom.